ArticleFrontiers in medicine2026
Case Report: Rare spontaneous hepatic rupture hemorrhage complicated by autoimmune liver disease.
Article in Frontiers in medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Autoimmune liver disease is predominantly characterized by autoimmune hepatitis and primary biliary cholangitis. In clinical practice, patients with autoimmune liver disease may progress to cirrhosis and subsequently develop multiple complications of decompensated cirrhosis, such as ascites, hepatic encephalopathy, and gastrointestinal hemorrhage. However, spontaneous hepatic rupture hemorrhage in patients with autoimmune liver disease is exceedingly rare. This article presents a case of presumed spontaneous hepatic rupture hemorrhage in a patient with autoimmune hepatitis-primary biliary cholangitis overlap syndrome and cirrhosis. Through multidisciplinary evaluation, conservative management was selected, achieving successful hemostasis. This report aims to provide a reference for the clinical recognition and management of such rare complications.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.